Eli Lilly and Company (NYSE: LLY) will commemorate its 140th anniversary today with activities at Lilly locations worldwide, including a ceremony to unveil a statue dedicated to founder Colonel Eli Lilly at global headquarters in Indianapolis.
Over 14 decades, the organization has contributed more than 100 medicines and significant medical advances, such as the first commercially available insulin, manufacturing and global distribution of the Salk polio vaccine and mental health breakthroughs such as anti-depressant Prozac® (fluoxetine). Today Lilly continues to progress its most robust pipeline in history with dozens of potential new medicines in mid- to late-stage development for cancer, diabetes, autoimmune disease, pain and Alzheimer’s disease.
“As Lilly celebrates 140 years, we’re keeping the vision of our founder alive – from our dedication in the lab to our impact in the community,” said John C. Lechleiter, Ph.D., Lilly chairman, president and chief executive officer, who began his career at Lilly as a chemist in 1979. “Colonel Eli Lilly started this company to put science to work fighting disease and encouraged his successors to ‘take what you find here and make it better and better.’ That vision pushes us daily to honor Colonel Lilly’s legacy and continue in our quest to discover new medicines to help make life better.”
To view the multimedia release go to:
http://www.multivu.com/players/English/7809951-eli-lilly-and-company-140th-anniversary/
Quest Diagnostics (NYSE: DGX), the world’s leading provider of diagnostic information services, commemorated its 50-year anniversary by awarding $150,000 in total grants to three organizations that share its goal to improve healthcare: The American Red Cross, the National Ovarian Cancer Coalition and Autism Speaks.
At a ceremony at the company’s flagship clinical laboratory in Teterboro, NJ, the company’s chairman, president and CEO Steve Rusckowski presented Health In Your Hands grants of $50,000 to representatives from each organization. Paul Brown, M.D., founder and former CEO of Quest’s predecessor company Metropolitan Pathology Laboratory, Inc. or MetPath, established in April, 1967, was also recognized at the event.
To view the multimedia release go to:
https://www.multivu.com/players/English/8080751-quest-diagnostics-50th-anniversary/
The present volume offers a new approach in the quest to discover the truth about nature. The main idea is to proceed, not by way of observation, but rationally by working out the implications of a formal signature of the world’s existence, an algebraic form called the Law of Laws. Find out more at http:/www.principleoftruerepresentation.com Non-fiction, philosophy, metaphysics
The Swiss watch world is about to be joined by an exciting new addition with a venerable name. Czapek, a watch brand that achieved considerable success in the nineteenth century, has been revived and is launching with a distinctive timepiece and an innovative sharing strategy to attract watch lovers.
Czapek & Cie was re-established by three entrepreneurs with a passion for fine watches and outstanding mechanics. The original founder, François Czapek was a Czech-born, Polish watchmaker, who arrived in Geneva, Switzerland, in 1832. In 1839 he founded Patek, Czapek & Cie with fellow pole Antoni Patek. For six years they produced exceptional watches.
At the end of their partnership, in 1845, he founded Czapek & Cie and became Purveyor to the French Emperor Napoleon the Third. At its height, the company had boutiques in Geneva, Warsaw and Paris, Place Vendôme.
“Czapek deserves to be revived, he was one of the great watchmakers of the nineteenth century, who brilliantly combined precision mechanics with extremely refined aesthetics”, says Xavier de Roquemaurel, spokesman for the team. Czapek’s timepieces, which are still coveted at auctions, reveal a quest for beauty through a poetic display of time.
To view the multimedia release go to:
http://www.multivu.com/players/uk/7684451-czapek-cie-19th-century-swiss-watch/
